WARNING: This product contains nicotine. Nicotine is an addictive chemical.

Vapor is not approved by the FDA. The Vapor Inhaler and Sublingual delivery devices, micelle Nicotine formulations and method of delivery have been filed with the FDA, awaiting Status of Equivalence approval as a Next Generation, Reduced Risk Nicotine Product.

The liquid Nicotine in Vapor is natural, 99.9% pure Nicotine liquid, extracted from the highest quality tobacco leaves. Rigorous testing and quality control processes ensure that every batch of micellized, Nicotine liquid meets our highest standard for purity and consistency. Each batch’s purity surpasses USP/EP standards.

Each Inhaler device delivers .5 milligrams of micelle Nicotine per spray actuation. Each Sublingual device delivers 1.0 milligrams of micelle Nicotine per spray actuation.

Whether using the Vapor Inhaler or Sublingual delivery device, each spray actuation delivers a consistent, metered dose of Nicotine. Users can choose their personal, desired level of Nicotine, knowing they can decrease the nicotine intake by two-thirds, while achieving an equivalent nicotine effect and user satisfaction.

Both the Vapor Inhaler and Vapor Sublingual Nicotine devices deliver approximately 200+ metered spray actuations.

Yes, Vapor’s NanoMist formulations include sucralose, an artificial sweetener and lactic acid, an organic acid produced naturally by the body and found in many foods like yogurt. Vapor’s formulations are FDA GRAS and have no other added chemicals. 

Vapor's ingredients consist of 99.9% pure Nicotine liquid, extracted from the highest quality tobacco leaves, natural flavor extracts, culinary ethanol and tetrafluoroethane, a propellant most commonly used in pharmaceutical, metered dose inhalers.

Both the Vapor Nicotine Inhaler and Vapor Nicotine Sublingual are available in the following flavors: Menthol, Spearmint, Peppermint, Wintergreen, Citrus, Coffee, Cinnamon and Berry.

A micelle is the process of converting key, active ingredients (Nicotine and flavor extracts) into tiny, nano dispersed particles and making them soluble in water and medical-grade propellant to optimize and carry the nano-sized ingredients (Micellized Nicotine) direct to the oral, mucosal membrane and human body's cells. The result is a highly concentrated formulation of nano-dispersed Nicotine, allowing the consumer to take two-thirds less nicotine while achieving the same desired satisfaction and user experience.

Yes, the empty Vapor device and components, HDPE plastic housing, aluminum canister and actuation valve are recyclable. 

On average, Vapor sells for $20 USD per Inhaler or Sublingual unit. 

- Each Inhaler consists of 100 mg of micellized Nicotine (Equivalent to 300 mg of nicotine).

 - Each Sublingual consists of 200 mg of micellized Nicotine (Equivalent to 600 mg of nicotine).

- The average cigarette delivers 1.5 mg of nicotine and 30 mg of nicotine per pack of cigarettes. The average cost of a pack of cigarette's in the U.S. is $8.00 USD.

- The average Vape consists of 5.0% nicotine Salts and generally ranges in price from $5 to $20 for disposable vapes, $10 to $30 for vape pens and $15 to $60 USD for vape pods. On average, a disposable vape pen with 2 ml of e-liquid lasts around 600 puffs.

- The average cost of nicotine oral pouches is between $4 and $5 USD and each container consisting of 15 to 20 synthetic nicotine Salt pouches. Nicotine pouches vary between 1.5 mg and 12 mg in nicotine strength. Most common nicotine pouches are sold in 3 mg and 6 mg nicotine strengths and 45 mg to 90 mg of nicotine per container.

Yes. Tetrafluoroethane (HFA-134a), also known as norflurane is a hydrofluorocarbon (HFC) and a common propellant in metered-dose inhalers (pMDIs) for delivering medication to the lungs. Used as a replacement for ozone-depleting chlorofluorocarbons (CFCs), Tetrafluoroethane (HFA-134a) is Generally Regarded as Safe (GRAS) by the FDA.

Yes. Air 2 LLC, a Colorado Limited Liability Company, owns Vapor’s intellectual property, its formulations, science and chemistry. To date The company has been issued three U.S. patents 12,016,401, 12,108,809, 12,262,756 and has filed an international patent application, PCT/US24/29212, May 14, 2024.

Yes. Both Vapor delivery devices, Inhaler and Sublingual are child safe. Each device has a locking base and cap which can be easily locked and unlocked by the user. See "How to Use" for additional use and safety instructions.

Currently, Air 2, LLC (the Company) is awaiting approval from the FDA for sale of its products in the United States. 

The products are currently being reviewed for international distribution and sales in India, Vietnam, South Korea, the UK, Netherlands, South America and Central America.